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Brief Technique Reportsend-diastolic diameter was improved in 5 patients; right
ventricular size and function improved in 3 patients. Three
late deaths due to carcinoid progression occurred postoper-
atively at 39, 5, and 30 months.DISCUSSION
Previous studies have shown that tricuspid and pulmo-
nary valve replacement can improve symptoms and survival
in patients with right heart failure due to carcinoid heart
disease.1 Improved functional status and cardiac chamber
size were also noted in our carcinoid patients with 4 valve
replacements. Notably, a PFO was present in only 3 pa-
tients, and each was detected only by intraoperative transe-
sophageal echocardiography with saline injection. Thus,
our experience documents that an intracardiac shunt is not
necessary for development of left-sided carcinoid valve dis-
ease, despite other reports.4,5From the Department of Surgery I, Tokyo Women’s Medical University, Tokyo,
Japan.
Disclosures: None.
Received for publication April 30, 2010; accepted for publication May 11, 2010;
available ahead of print June 11, 2010.
Address for reprints: Masato Kanzaki, MD, Department of Surgery I, TokyoWomen’s
Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
(E-mail: kanzaki@chi.twmu.ac.jp).
J Thorac Cardiovasc Surg 2010;140:1434-6
0022-5223/$36.00
Copyright  2010 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2010.05.007
1434 The Journal of Thoracic and Cardiovascular SurCONCLUSIONS
Although carcinoid heart disease with involvement of all
4 valves is rare, we conclude that quadruple valve replace-
ment in symptomatic patients is a reasonable option that can
result in functional improvement with acceptable risks.
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1129.e1-6.Successful resection of localized pulmonary mucormycosis after bone
marrow transplantation using a virtual 3-dimensional pulmonary
model on a personal computerHideyuki Maeda, MD, Masato Kanzaki, MD, Tamami Isaka, MD, PhD, and Takamasa Onuki, MD, PhD,
Tokyo, JapanMucormycosis is a rare and fatal infectious disease. Pulmo-
narymucormycosismost often occurs in patients with neutro-
penia, immune deficiencies, malignant disease, malnutrition,
diabetes, and trauma, as well as in patients undergoing organ
transplantation or chelation therapy involving deferox-
amine.1,2 For control of the underlying disease, a polyene
administration and surgical resection of infected lung
segments may prove helpful. We report a case of localized
pulmonary mucormycosis after bone marrow transplantation
that was successfully resected using a virtual 3-dimensional
pulmonary model on a personal computer.CLINICAL SUMMARY
A 28-year-old man, treated with allogenic bone marrow
transplantation for acute lymphatic leukemia in March
2009, had progressive dyspnea and productive cough in
May 2009. Chest radiography and computed tomography
(CT) revealed a fungus ball in the left upper lobe of the
lung (Figure 1, A). Mucor was detected by bronchoscopic
biopsy. When liposomal amphotericin B (L-AMB) was ad-
ministered, the size of the fungus ball reduced immediately
(Figure 1, B). However, because the patient became resis-
tant to L-AMB, he was referred to our division for surgery
for pulmonary mucormycosis. Preoperative blood chemis-
try analysis showed pancytopenia and renal insufficiency
(the serum creatinine level 1.94 mg/dL) caused by ongoing
L-AMB administration. Chest CT demonstrated an 18-mm
cavitary mass in S1þ2c of the left lung. For preoperative
simulation of surgical resection, we used free software ap-
plication such as CTTRY, where we could mark on pulmo-
nary arteries, veins, bronchi, and fungus ball of the images
on high-resolution CT images. With 60 2-mm high-
resolution CT images of the fungus ball and hilum, in DI-
COM (Digital Imaging and Communications in Medicine)
format, we obtained 3-dimensional images for a patientgery c December 2010
FIGURE 1. A, A computed tomogram (CT) shows a fungus ball in the S1þ2 of the left upper lobe of the lung. B, The size of a fungus ball was decreased
by administering liposomal amphotericin B (L-AMB) before the operation. C, Three-dimensional images of the left lung based on high-resolution CTwith
2-mm CT slices. Pulmonary arteries, veins, and bronchi are shown in red, blue, and yellow. A fungus ball was located in S1þ2 of the left lung. D and E,
Comparison of 3-dimensional images and intraoperative findings. T, Tumor; PA, interlobar pulmonary artery;+, lingular segmental pulmonary artery (A4
þ5); ++, apicoposterior segmental branch (A1þ2c); LUL, left upper lobe; LLL, left lower lobe.
Brief Technique Reportsusing Metasequoia shareware (Figure 1, C). We planned the
operation based on the 3-dimensional image; 3 subsegments
(ie, S1þ2c, S3a, and S4a) needed to be resected to remove
the fungus ball completely. Video-assisted thoracoscopic
surgical resection of the subsegments was performed
(Figure 1, D and E). Macroscopic examination of the surgi-
cal specimen revealed a 20-mm left upper lobe fungus ball
cavity (Figure 2, A). Microscopically, a Grocott stain high-
lighted the fungal structures (Figure 2, B). The patient’sThe Journal of Thoracic and Carpostoperative course was uneventful. He was discharged
on postoperative day 9. He is active without respiratory lim-
itation.
COMMENT
Successful treatment of mucormycosis consists of early
diagnosis, correction of underlying risk factors, performing
surgical resection, and prompt antifungal therapy. It is dif-
ficult to diagnose pulmonary mucormycosis, because chestdiovascular Surgery c Volume 140, Number 6 1435
FIGURE 2. A, Macroscopic findings. The size of the mass is 20 mm. A fungus ball is present inside the mass (white arrow). B, Photomicrograph of the
lesion shows characteristic broad, aseptate hyphae with stubby, right-angled, fingerlike branches in a background of necrotic tissue (Grocott’s methenamine
silver stain, original magnification 3200).
Brief Technique Reportsradiographic findings are variable, culture results are
commonly negative, and there are currently no routinely
available serum immunologic assays for it. Pulmonary
mucormycosis is usually diagnosed by histopathology.
Transbronchial biopsy procedures or a surgical lung biopsy
procedure may be required to obtain an adequate specimen
for diagnosis. Generally, a polyene, such as the AMB or L-
AMB, is administered as primary antifungal therapy. How-
ever, blood vessel thrombosis and resulting tissue necrosis
during mucormycosis can result in poor penetration of anti-
fungal agents to the site of infection. Therefore, surgical de-
bridement of necrotic tissues may be critical for complete
eradication of mucormycosis.3 Roden and associates4 re-
ported that the mortality rate of pulmonary mucormycosis
is 76% (170/220 patients). However the patients who un-
derwent surgical resection were significantly more likely
to survive than those who did not.4
In this case, although the patient’s pulmonary mucormy-
cosis had been controlled and localized by administering
L-AMB, surgical resection was selected. We prefer seg-
mentectomy or more conservative resection to lobectomy
for peripheral, small, stage I non–small cell lung cancer.
Therefore, we performed multi-subsegmentectomy for the
localized pulmonary mucormycosis. Because we constantly
focus on the possibility of lung-saving procedures, we
attempted to reconstruct using anatomically correct images1436 The Journal of Thoracic and Cardiovascular Surwith a freeware program. After the images had been
uploaded to a personal computer, the pulmonary arteries,
pulmonary veins, and bronchi were traced in the images.
The location and thickness of the bronchi and pulmonary
vasculature were rendered as different-sized cylinders.
Next, on the basis of the resulting numerical data, 3-dimen-
sional images were reconstructed. The reconstructed im-
ages can be manipulated by virtual surgical procedures
such as reshaping, cutting, and moving.5
Although the incidence of mucormycosis is increasing,
surgical excision of localized disease appears to be the
most reliable method of treating pulmonary mucormycosis.
In conclusion, early detection and aggressive treatment
for pulmonary mucormycosis offer the best chance of pa-
tient survival.
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